Tyruko Европейски съюз - български - EMA (European Medicines Agency)

tyruko

sandoz gmbh - натализумаб - multiple sclerosis, relapsing-remitting; multiple sclerosis - Имуносупресори - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 и 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.

Briumvi Европейски съюз - български - EMA (European Medicines Agency)

briumvi

neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - Имуносупресори - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.

Strepsils Cool 1,2 mg/0,6 mg lozenges България - български - Изпълнителна агенция по лекарствата

strepsils cool 1,2 mg/0,6 mg lozenges

reckitt benckiser healthcare international ltd. - АНТИСЕПТИЦИ И ДЕЗИНФЕКТАНТИ - 1,2 mg/0,6 mg lozenges

Gaviscon Strawberry Tablets 250 mg/133,5 mg/80 mg chewable tablets  България - български - Изпълнителна агенция по лекарствата

gaviscon strawberry tablets 250 mg/133,5 mg/80 mg chewable tablets 

reckitt benckiser healthcare international ltd. - Други лекарства за лечение на пептична язва и гастро-езофагеална отлив (горд) - 250 mg/133,5 mg/80 mg chewable tablets